Search - tctmd.com

Displaying 161 - 180 of 467

Sort: Relevancy | Date

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Conference News ACC 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Michael O'Riordan

April 02, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Daily News

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Yael L. Maxwell

February 22, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Yael L. Maxwell

December 20, 2021

News Features

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

Caitlin E. Cox

December 16, 2021

Advertisement

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

More Evidence Links Breast Arterial Calcification and CVD Risk

March 2022 News Roundup

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content